comprehensive -WSS

comprehensive

author：focus 2025-09-06 03:33:06 - browse：11346

WASHINGTON — Grail is aggressively lobbying to get Medicare to pay for its cancer-screening test Galleri — but experts tell STAT that the company has a far more complicated path to that end than the makers of most medicines or medical devices.

Grail’s controversial blood test Galleri screens for multiple cancers. The Food and Drug Administration has not yet approved it, so Medicare hasn’t had to make a decision on whether to cover it or not. Right now, most people pay for it out of pocket. It runs about $950.

In general, Medicare covers FDA-approved medicines and medical devices that help diagnose or treat disease or injury. But there’s a catch for Grail: Medicare doesn’t cover tests that simply screen healthy people, as Galleri does.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Medical experts are missing from AI regulatory conversations

leisure time

focus

WSS

Norman Reedus' Daryl Dixon

Trump demands the U.S. pay no more for drugs than other countries … again

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

Medical experts are missing from AI regulatory conversations

Plane’s emergency slide plummets from sky, hits Chicago home

Heart attack and stroke risk calculators need revising

explore

comprehensive

leisure time

Heart attack and stroke risk calculators need revising

Guidelines to prevent youth baseball injuries need more muscle

Walensky prepares to leave CDC — and Congress — behind

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

State Dept. review finds Biden bears some blame for Afghanistan failures

BioMarin wins approval for gene therapy to treat hemophilia A

BioMarin wins approval for gene therapy to treat hemophilia A

At least 13 dead in Texas as scorching temps continue

Medical leaders decry Supreme Court decision on affirmative action

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

knowledge

New air purifier tech could be key to improving indoor air quality

Man who had jail sentence commuted by Trump arrested again

United colonoscopy coverage change 'may cost lives,' doctors say

Alkermes shareholders re

Medical leaders decry Supreme Court decision on affirmative action

Virginia high school admissions case could be legal follow

leisure time

explore

focus

leisure time